Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.66B.
ENTERPRISE VALUE (EV)
$1.66B
ANI Pharmaceuticals, Inc.
Market Cap
$1.62B
Enterprise Value (EV)
$1.66B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| ANI Pharmaceuticals, Inc. (ANIP) | $1.62B | $1.66B |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.61B | $1.62B |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.64B | $1.12B |
| Omnicell, Inc. (OMCL)vs › | $1.60B | $1.51B |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | $2.13B |
| Personalis, Inc. (PSNL)vs › | $1.70B | $1.65B |
| uniQure N.V. (QURE)vs › | $1.54B | $1.19B |
| Innoviva, Inc. (INVA)vs › | $1.54B | $1.24B |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | $1.68B |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | $1.68B |
Market Cap
$1.62B
Total Debt
$325.19M
Cash
$285.58M
Enterprise Value
$1.66B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
